ResearchSafe

Telmisartan (Telmisartan (ARB / Partial PPAR-gamma Agonist))

Category: Cardiovascular. Status: FDA-approved drug.

An FDA-approved angiotensin receptor blocker (ARB) for blood pressure that is a favorite in longevity circles because, unlike other ARBs, it also partially activates PPAR-gamma, giving it metabolic and mitochondrial benefits beyond blood pressure control.

How it works

Blocks the angiotensin II type 1 (AT1) receptor to lower blood pressure and reduce vascular inflammation, while also acting as a partial PPAR-gamma agonist that improves insulin sensitivity, lipid handling, and mitochondrial biogenesis.

Key facts

  • Molecular weight: 514.62 Da
  • Half-life: ~24 hours
  • Bioavailability: ~42-58% oral
  • Storage: Room temperature, protect from moisture.

Dosing overview

  • Typical dose: 20-80 mg per day
  • Frequency: Once daily
  • Duration: Ongoing
  • Route: Oral tablet

Protocol notes

  • Common start is 40 mg once daily, adjusted to 20-80 mg by blood pressure response.
  • Its long half-life gives smooth 24-hour coverage from a single daily dose.
  • Longevity users favor it over other ARBs for the added PPAR-gamma metabolic effects.

Reported benefits

  • Blood pressure control
  • PPAR-gamma metabolic benefits
  • Improved insulin sensitivity
  • Vascular anti-inflammatory effects
  • Cardio- and reno-protection
  • 24-hour coverage

Possible side effects

  • Dizziness/low blood pressure
  • Hyperkalemia
  • Rare kidney function changes
  • Contraindicated in pregnancy
  • Fatigue

Research

  • Telmisartan PPAR-gamma activity (2018): Uniquely among ARBs, telmisartan partially activated PPAR-gamma, improving insulin sensitivity and lipid profiles.
  • ONTARGET cardiovascular outcomes (2008): Telmisartan was as effective as ramipril for reducing cardiovascular events with better tolerability.

Community reviews of Telmisartan

Rated 4.8 out of 5 from 5 community reviews by ResearchSafe members.

  • dose_diary_alex rated it 4/5 - Worth adding to the protocol: Telmisartan has been a worthwhile addition. I am data-driven and tracked relevant markers before, during, and after. The improvement is measurable and correlates with the intervention timeline. What sets this apart from some compounds I have tried is the consistency. Benefits did not fluctuate wildly or disappear. They built up and maintained. That gives me confidence in the mechanism. Tolerance has been excellent. Nothing in my bloodwork or subjective experience raised any flags. This is the kind of compound that does its job quietly without causing problems. Exactly what you want.
  • dose_math_derek rated it 5/5 - Genuinely effective after 6 months: Been using Telmisartan for about 6 months and the results are clear. Not overnight dramatic, but a steady, consistent improvement that became undeniable by the end of the first month. The mechanism makes sense based on what I have read in the literature, and my subjective experience matches the expected timeline. Benefits built gradually and plateaued at a good level. Side effects were minimal to none at the dose I used. Followed proper protocols for sourcing, storage, and administration. Would recommend to others who have done their research and have realistic expectations.
  • recovery_rachel rated it 5/5 - Noticed clear benefits within weeks: Added Telmisartan to my protocol about 2 months ago and it has earned its place. The benefits became noticeable around week 2-3 and have been consistent since. What I appreciate about this compound is the predictability. It does what the research suggests it should do, at roughly the timeline you would expect. No surprises, no dramatic swings, just steady improvement. No notable side effects to report at my dose. Sourcing is always the challenge with research compounds, insist on third-party testing. Storage and reconstitution per standard protocols. Plan to continue.
  • compound_curious rated it 5/5 - Consistent improvement over 1 month: Added Telmisartan to my protocol about 1 month ago and it has earned its place. The benefits became noticeable around week 2-3 and have been consistent since. What I appreciate about this compound is the predictability. It does what the research suggests it should do, at roughly the timeline you would expect. No surprises, no dramatic swings, just steady improvement. No notable side effects to report at my dose. Sourcing is always the challenge with research compounds, insist on third-party testing. Storage and reconstitution per standard protocols. Plan to continue.
  • n_of_one rated it 5/5 - Solid compound with real results: Been using Telmisartan for about 3 weeks and the results are clear. Not overnight dramatic, but a steady, consistent improvement that became undeniable by the end of the first month. The mechanism makes sense based on what I have read in the literature, and my subjective experience matches the expected timeline. Benefits built gradually and plateaued at a good level. Side effects were minimal to none at the dose I used. Followed proper protocols for sourcing, storage, and administration. Would recommend to others who have done their research and have realistic expectations.

Compare Telmisartan

Community discussions about Telmisartan

Research and educational reference only. Not medical advice.